Purchase Order HHSN269201700501P
- Not listed
- This $4,884 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is not associated with a set-aside. Under this award, Miltenyi Biotec will supply the NIH Clinical Center with proprietary CliniMACS cell isolation reagents and consumables required for Good...
- This is a federal contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract award, valued at $20,493.00, is a firm fixed-price purchase order to supply Miltenyi Biotec's proprietary CliniMACS cell isolation reagents, consumables, and related services to support the NIH's cell therapy manufacturing capabilities. This single-award...
- The National Institutes of Health (NIH) Clinical Center awarded a Firm Fixed Price Purchase Order contract valued at $3,600.00 to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of specialized biotechnology products. The contract, which does not have a set-aside designation, runs through September 22, 2023 and provides for the delivery of Miltenyi Biotec's proprietary cell separation reagents, consumables, and technical support services to support the NIH Clinical Center's cell...
- This federal contract award to Miltenyi Biotec, Inc. is for the delivery of specialized laboratory equipment, reagents, and consumables to the National Institutes of Health (NIH) Clinical Center. The $5,406.00 firm-fixed-price purchase order includes products such as the GentleMACS Tissue Dissociation Kit and GentleMACS C Tubes, provided at no additional cost to the government. The award is part of a larger $2.3 million single-award indefinite delivery contract (IDC) that Miltenyi Biotec holds...
- This federal contract award from the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center was issued to Miltenyi Biotec, Inc., a global biotechnology company that provides products and services to support biomedical research and cell and gene therapy. The $1,090,887.29 Firm Fixed Price Delivery Order contract is for the provision of proprietary CliniMACS cell isolation reagents and consumables compatible with government-owned Miltenyi cell separation...
- This $3,742.63 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract supports the delivery and installation of Miltenyi's proprietary CliniMACS cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as associated reagents and consumables. This award is a standalone...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a $1,722,610.45 firm-fixed-price delivery order contract to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of biotechnology products and services. The contract is for the provision of proprietary CliniMACS cell isolation reagents and consumables compatible with government-owned Miltenyi cell separation instruments. These reagents and kits are used by the NIH Clinical...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company. The award has a firm fixed price contract type and a potential value of $967,646.15. It is for the provision of proprietary CliniMACS cell isolation reagents and consumables compatible with government-owned Miltenyi cell separation instruments. These products are used by the NIH Clinical Center Cell...
- This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, was made by the National Institutes of Health (NIH). The $12,867 firm fixed-price purchase order covers the supply of Miltenyi antibodies, cell separation starter kits, and related consumables. Miltenyi Biotec has an extensive history as a prime contractor for numerous federal agencies, including the NIH, Department of Veterans Affairs, and Department of Defense, providing a range of specialized laboratory...
- The federal contract award is for a service agreement with Miltenyi Biotec, Inc., a global biotechnology company that specializes in scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract, valued at $10,180.00, is a firm fixed-price purchase order awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a civilian agency within the National Institutes of Health (NIH). The contract runs from August 1, 2024, to...
This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company, to provide specialized scientific instruments, reagents, and services to support the NIH's biomedical research and cell therapy development programs. The $5,420 firm fixed-price purchase order has a period of performance through September 2023. Miltenyi Biotec holds a significant $2.3 million indefinite delivery contract (IDC) with the NIH Clinical Center, awarded in June 2023, to supply proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options to extend to 2027. This sole-source contract ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing CliniMACS instrumentation for use in GMP-compliant production of investigational cell therapy products for NIH clinical trials. The award was not set aside for any particular business category. Miltenyi Biotec, as the prime contractor, has extensive experience providing a wide range of cell separation, analysis, and processing technologies to support numerous federal agencies, including the NIH, Department of Veterans Affairs, Food and Drug Administration, Department of Defense, and Centers for Disease Control and Prevention.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 7/12/17 | |
| P00001 | Other Administrative Action | ($61) | 7/12/17 |